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Abstract
Background: Intervertebral disc (IVD) cells experience a broad range of physicochemical stimuli under physiologic
conditions, including alterations in their osmotic environment. At present, the molecular mechanisms underlying
osmotic regulation in IVD cells are poorly understood. This study aims to screen genes affected by changes in
osmotic pressure in cells of subjects aged 29 to 63 years old, with top-scoring pair (TSP) method.
Methods: Gene expression data set GSE1648 was downloaded from Gene Expression Omnibus database, including
four hyper-osmotic stimuli samples, four iso-osmotic stimuli samples, and three hypo-osmotic stimuli samples. A
novel, simple method, referred to as the TSP, was used in this study. Through this method, there was no need to
perform data normalization and transformation before data analysis.
Results: A total of five pairs of genes ((CYP2A6, FNTB), (PRPF8, TARDBP), (RPS5, OAZ1), (SLC25A3, NPM1) and (CBX3,
SRSF9)) were selected based on the TSP method. We inferred that all these genes might play important roles in
response to osmotic stimuli and age in IVD cells. Additionally, hyper-osmotic and iso-osmotic stimuli conditions
were adverse factors for IVD cells.
Conclusions: We anticipate that our results will provide new thoughts and methods for the study of IVD disease.
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Background
Intervertebral disc (IVD) disease is a frequent surgical
disease characterized by a series of deleterious changes
in cellularity that lead to loss of extracellular matrix
structure, altered biomechanical loading, and symptomatic
pain [1]. Although studies of biological therapeutics
for IVD disease have been ongoing over a decade, few
treatments have progressed to clinical testing and none
is current commercially available [2-4]. This may be,
primarily, due to a limited understanding of disease
etiology. Therefore, further work is needed to explore
its pathogenesis from early to later stages.
The IVD, an avascular and lymphatic tissue, is composed
of different zones, including the annulus fibrosus, the
nucleus pulposus, and the transition zone [5]. The IVD
cells can secrete a complex extracellular matrix containing
lots of water and negatively charged proteoglycans,
which confer a net negative charge on the tissue and give
the tissue a higher extracellular osmolarity than other
tissues [6,7]. Previous studies have shown that IVD cells
respond strongly to changes in the osmotic environment
by altering mRNA expression [8]. In particular, the genes
encoding proteins related to ion transport, cytoskeletal
organization, growth factors, and cytokines have been
demonstrated to show different regulation response to
osmotic conditions in IVD cells [6,9,10]. Meanwhile,
both hyper- and hypo-osmotic conditions can induce
changes of cell volume and calcium signaling in IVD cells
[11,12]. However, the molecular mechanisms involved in
the response of IVD cells to osmotic pressure are still
not clearly understood.
In the present study, gene expression profile data of
IVD cells exposed to iso-osmotic, hyper-osmotic, and
hypo-osmotic conditions were downloaded. Top scoring
pair (TSP) is a novel, simple statistical method that can
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classify gene pairs into relevant classes based on their
scores [13-15]. In this study, the TSP method was used
to screen the pairs of differentially expressed genes in
different osmotic stimuli conditions. Our findings might




Expression profiling of GSE1648 [9] was downloaded from
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/), based on GPL96 [HG-U133A] Affymetrix
Human Genome U133A Array. A total of 11 human
IVD tissue samples were collected, including four hyper-
osmotic stimuli samples (ages: 63, 62, 50, and 29, respect-
ively), four iso-osmotic stimuli samples (ages: 63, 62, 50,
and 29, respectively) and three hypo-osmotic stimuli
samples (ages: 63, 50, and 29, respectively).
Top-Scoring Pair (TSP)
Recently, gene pair response to environmental changes
has been assessed using the TSP method, which is based
on pair-wise comparisons of gene expression values within
each tissue microarray [16]. Distinction between two clas-
ses depended on the gene pairs with the highest ranking
value (called “score”). In the current study, the higher
score of the gene pairs indicated the stronger correlation
between the expression values of gene-pairs and tissues.
Algorithm overview of the TSP method
Detailed information about the TSP method was de-
scribed by Geman et al. [16]. Here, we give a brief and
intuitive description of this method. A gene expression
profile consists of G genes and N samples (i.e., hypo-
osmotic) participating in the training micro-array dataset.
The data is represented as a G ×N matrix, in which the
expression value of gth gene from the nth sample is de-
noted as “Xgn”. Each column represents a gene expression
profile of G genes and each row represents observations
of a particular gene over N samples. Each sample has a
class label of either 1 or 2. For the simplicity of calcula-
tions, it is assumed that there are only two classes, and
we assume that samples 1 to N1 (N1 < N) are labeled as
class 1 (e.g., hyper-osmotic) and samples (N1 + 1) to N are
labeled as class 2 (e.g., iso-osmotic). For each pair of genes
(i, j), two probabilities are calculated as pij (1) and pij (2):












I(Xin < Xjn) is the indicator function defined as:
I Xin<Xjnð Þ ¼ 1; if Xin<Xjnð Þ0; if Xin>Xjnð Þn ¼ 1; 2…N:

TSP is a rank-based method, so for each pair of genes
(i, j), the “score” denoted as Δij is calculated as follows:
Δij ¼ pij 1ð Þ−pij 2ð Þ
 
In other words, pij (1) (or pij (2), respectively) is the
estimated probability of observing Xi less than Xj in class
1 (or class 2). Δij is the absolute value of the difference
between pij (1) and pij (2) and represents the difference
of pairs of genes (i, j) between class 1 and class 2. In this
study, the larger the Δij (close to 1), the greater the differ-
ence of pairs of genes (i, j) between class 1 and class 2,
indicating that pairs of genes (i, j) may be related to the
tissues. Meanwhile, Δij >0.6 was set as cut-off criteria.
In addition, the TSP method focuses on gene-pair (i, j)
matching between two classes.
In the present study, we divided the samples into three
groups: hyper-osmotic vs. hypo-osmotic group, hyper-
osmotic vs. iso-osmotic group, and iso-osmotic vs. hypo-
osmotic group.
Osmotic pressure, age, and related genes
To reduce the false positive rate, we analyzed the potential
relationship between age and osmotic pressure based
on the Δij score. All pairs of genes with the largest score
(Δij = 0.75) and that repeatedly appeared in the three
groups (≥2) were selected. Then, the expression level of
gene pairs from hyper-osmotic stimuli samples with the
ages of 63, 62, 50, and 29 was analyzed, respectively, as
was the expression of iso-osmotic stimuli samples (ages:
63, 62, 50, and 29, respectively) and hypo-osmotic stimuli
samples (ages: 63, 50, and 29, respectively), in order to
present a tendency of gene expression along with age.
Results
Osmotic pressure and related genes
Based on the TSP method, a total of 65 gene pairs were
selected from the three groups, including 34 gene pairs
in the hyper-osmotic vs. hypo-osmotic group (Table 1),
7 in hyper-osmotic vs. iso-osmotic group (Table 2), and
24 in iso-osmotic vs. hypo-osmotic group (Table 3). For
the hyper-osmotic vs. hypo-osmotic group (Table 1), a
total of 34 gene pairs were obtained with Δij >0.6, in-
cluding a gene pair with Δij = 1, 11 gene pairs with Δij =
0.75, and 22 gene pairs with Δij = 0.666667. For the
hyper-osmotic vs. iso-osmotic group (Table 2), a total
of 7 gene pairs were obtained with Δij >0.6 and the Δij
were all = 0.75. For the iso-osmotic vs. hypo-osmotic
group (Table 3), a total of 24 gene pairs were obtained
at Δij >0.6, including a gene pair with Δij = 1, 7 with Δij =
0.75, and 16 with Δij = 0.666667.
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Age and related genes
As shown in Table 4, a total of five gene pairs might
have potential relationships between age and osmotic
pressure, including (CYP2A6, FNTB), (PRPF8, TARDBP),
(RPS5, OAZ1), (SLC25A3, NPM1), and (CBX3, SRSF9).
For the (CYP2A6, FNTB) pair, at the ages of 50–63,
the gene expression value of CYP2A6 was more than
Table 1 The screening results of pairs of genes in
hyper-osmotic vs. hypo-osmotic group based on the
top-scoring pair method
First ID Second ID pij(1) pij(2) Δij
1 21 0 0.666667 0.666667
1 35 0 0.666667 0.666667
5 10 1 0.333333 0.666667
8 18 0.25 1 0.75
9 10 1 0.333333 0.666667
13 17 0.25 1 0.75
23 31 0.75 0 0.75
23 85 1 0.333333 0.666667
29 60 0.25 1 0.75
29 62 0 0.666667 0.666667
29 76 0 0.666667 0.666667
30 78 0 0.666667 0.666667
31 85 1 0.333333 0.666667
32 49 1 0.333333 0.666667
33 46 0.25 1 0.75
34 85 1 0.333333 0.666667
37 38 0.25 1 0.75
40 80 0.75 0 0.75
45 98 0.75 0 0.75
51 85 1 0.333333 0.666667
57 85 1 0.333333 0.666667
58 65 0.75 0 0.75
58 88 1 0.333333 0.666667
61 88 1 0.333333 0.666667
62 88 0.75 0 0.75
62 99 1 0.333333 0.666667
63 94 0 0.666667 0.666667
65 93 1 0.333333 0.666667
67 69 1 0.333333 0.666667
68 74 0 0.666667 0.666667
72 75 1 0.333333 0.666667
76 88 0.75 0 0.75
76 99 1 0 1
80 86 0 0.666667 0.666667
Footnote: First ID represents genes in intervertebral disc cells with hyper-osmotic
stimuli. Second ID represents genes in intervertebral disc cells with
hypo-osmotic stimuli.
Table 2 The screening results of pairs of genes in
hyper-osmotic vs. iso-osmotic group based on the
top-scoring pair method
First ID Second ID pij(1) pij(2) Δij
21 41 0 0.75 0.75
37 51 0.75 0 0.75
37 85 1 0.25 0.75
51 84 0 0.75 0.75
58 65 0.75 0 0.75
58 68 0.75 0 0.75
71 92 0.75 0 0.75
Footnote: First ID represents genes in intervertebral disc cells with hyper-osmotic
stimuli conditions. Second ID represents genes in intervertebral disc cells with
iso-osmotic stimuli conditions.
Table 3 The screening results of pairs of genes in
iso-osmotic vs. hypo-osmotic group based on the
top-scoring pair method
First ID Second ID pij(1) pij(2) Δij
2 8 1 0.333333 0.666667
9 10 1 0.333333 0.666667
13 17 0.25 1 0.75
19 41 1 0.333333 0.666667
21 41 0.75 0 0.75
22 54 1 0.333333 0.666667
23 85 1 0.333333 0.666667
26 36 1 0.333333 0.666667
29 62 0 0.666667 0.666667
30 78 0 0.666667 0.666667
31 84 1 0.333333 0.666667
31 85 1 0.333333 0.666667
34 45 0 0.666667 0.666667
37 45 0 1 1
37 51 0 0.666667 0.666667
40 84 1 0.333333 0.666667
43 45 0 0.666667 0.666667
45 98 0.75 0 0.75
49 66 0 0.666667 0.666667
49 96 0.25 1 0.75
51 84 0.75 0 0.75
58 76 0.25 1 0.75
70 71 1 0.333333 0.666667
71 97 0.25 1 0.75
Footnote: First ID represents genes in intervertebral disc cells with iso-osmotic
stimuli. Second ID represents genes in intervertebral disc cells with
hyper-osmotic stimuli.
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that of FNTB in both hyper-osmotic and iso-osmotic
stimuli samples, and the situation was reversed in the
hypo-osmotic stimuli samples. However, at age 29, the
gene expression value of CYP2A6 was always less than
that of FNTB.
For the (PRPF8, TARDBP) pair, at the ages of 29–63, the
expression value of PRPF8 was more than that of TARDBP
in both hyper-osmotic and hypo-osmotic stimuli samples.
In iso-osmotic stimuli samples, the expression level of
PRPF8 was similar to that of TARDBP.
For the (RPS5, OAZ1) pair, at the ages of 29–62, the
expression level of RPS5 was always lower than that of
OAZ1 in both hyper-osmotic and iso-osmotic stimuli
samples; however, the situation was reversed at the
age of 63. Meanwhile, in hypo-osmotic stimuli samples,
the expression level of RPS5 was always higher than
that of OAZ1.
For the (SLC25A3, NPM1) pair, the gene expression
values were reversed in different osmotic pressure.
At the ages of 29–63, the gene expression value of
SLC25A3 was always larger than that of NPM1 in
both hyper-osmotic and hypo-osmotic stimuli samples.
Meanwhile, the situation was reversed in the iso-osmotic
stimuli samples except at the age of 29.
For the (CBX3, SRSF9) pair, at the ages of 29–63, the
gene expression value of CBX3 was always larger than
that of SRSF9 in both iso-osmotic and hypo-osmotic
stimuli samples. However, in the hyper-osmotic stimuli
samples, the gene expression value of CBX3 was more
than that of SRSF9 at the age of 29 and the situation was
reversed at the age of 50–63.
All these results indicated that the expression level of
these gene pairs ((CYP2A6, FNTB), (PRPF8, TARDBP),
(RPS5, OAZ1), (SLC25A3, NPM1) and (CBX3, SRSF9)) at
different osmotic pressures did not change at an early
age, but was reversed in old age.
Discussion
In the current study, it was shown that five gene pairs
might be involved in the potential interaction between
osmotic pressure and age, (CYP2A6, FNTB), (PRPF8,
TARDBP), (RPS5, OAZ1), (SLC25A3, NPM1) and (CBX3,
SRSF9). The expression level of the five gene pairs was
not influenced by the changes in osmotic pressure at an
early age, but was influenced in old age. These results
suggest that these gene pairs may be associated with the
regulation mechanism of the senescence of IVD tissue
and that the IVD tissue of aged people may be sensitive
to the changes in osmotic pressure as a result of wearing
and aging.
Cytochrome P450 2A6 (CYP2A6) is a member of the
cytochrome P450 (CYP) mixed-function oxidase system,
which is involved in the oxidation of nicotine and cotinine,
and the metabolism of several pharmaceuticals, carcino-
gens, and coumarin-type alkaloids [17-20]. It has been
reported that CYP may be involved in the activation of
caspase 12 that acts directly on the cell and mediates the
effector caspase 3 resulting in apoptosis [21]. The FNTB
gene encodes the protein farnesyltransferase subunit beta
which plays an important role in protein farnesylation,
regulation of cell proliferation, microtubule complex, and
protein farnesyltransferase complex [22,23]. In addition,
we found the expression value of the FNTB gene was less
than that of the CYP2A6 gene both in hyper-osmotic and
iso-osmotic conditions at an old age. Therefore, we inferred
that the FNTB gene and the CYP2A6 gene may play oppos-
ite roles in IVD cells and that the hyper-osmotic conditions
at an old age may be a negative factor for IVD cells.
PRPF8, together with PRPF3 and PRFP31, encodes spli-
cing factors and accounts for approximately 15% of families
with autosomal dominant retinitis pigmentosa in the
UK [24]. No report has revealed an association between
the expression of PRPF8 and IVD. Meanwhile, TARDBP,
Table 4 The screening result of osmotic stimuli and age in intervertebral disc cells
Term H63 H62 H50 H29 I63 I62 I50 I29 L63 L50 L29
Gene name
CYP2A6 295.0 254.8 254.1 313.8 252.6 227.8 276.0 235.8 198.4 160.7 202.9
FNTB 203.3 125.5 173.0 345.8 152.3 189.2 145.8 284.6 215.8 252.5 224.7
PRPF8 2524.9 1718.9 1835.8 1770.8 2300.4 1583.1 1114.4 1858.9 2568.2 1633.9 1696.9
TARDBP 661.2 1376.6 1318.0 1676.1 1027.4 1585.4 1149.8 1907.7 925.3 873.1 1198.6
RPS5 12991.9 7421.0 7272.1 9049.5 9314.9 7835.8 7309.5 8288.9 11266.1 9597.2 9900.7
OAZ1 7997.4 7819.5 7895.4 9254.5 7333.8 8252.4 7572.8 9327.2 8224.7 9151.1 9733.9
SLC25A3 10720.2 9369.4 7140.9 9115.2 8745.7 9064.5 6827.8 8444.5 10780.3 7778.3 9579.1
NPM1 9818.2 8637.1 5232.9 6995.0 10720.1 9126.9 7056.0 8196.5 9834.5 6465.2 8610.2
CBX3 1652.5 1798.9 2067.2 2568.6 2040.8 2078.3 2900.1 2671.4 1992.7 2375.8 2444.9
SRSF9 2073.6 2120.3 2124.0 1361.8 2004.9 1826.6 2576.8 1757.2 1797.8 2304.2 1917.4
Footnote: (1) H, I, L represent hyper-osmotic stimuli, iso-osmotic stimuli, and hypo-osmotic stimuli, respectively. (2) The number of H/I/L represents the age.
(3) The data in the table is the expression value of each gene in different osmotic stimuli conditions and ages.
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encoding TAR-DNA binding protein (also known as TDP-
43 proteins), is one of the principal genes responsible for
the adult onset form of amyotrophic lateral sclerosis
(ALS), displaying a TDP-43 positive skein-like inclusions
in the anterior horn of the spinal cord and inferior olive
[25]. It has been suggested that the calpain-dependent
cleavage of TDP-43 plays a crucial role in ALS [26]. In
the present study, the expression level of PRPF8 was
larger than that of TARDBP in both hyper-osmotic and
hypo-osmotic stimuli samples, especially at an old age.
These results suggested a greater susceptibility of PRPF8
than TARDBP to osmotic stimuli response.
RPS5 encodes ribosomal protein s5 and has been
suggested as one of the most stable reference genes for
qPCR analysis of degenerated nucleus pulposus tissue
(a fundamental component of IVD degeneration) in dogs
[27]. OAZ1 encodes ornithine decarboxylase antizyme 1, a
negative regulator of cellular polyamines, and has been
suggested as a potential genetic marker of vascular events
[28]. To date, the contribution of OAZ1 to IVD has
not been explored. In our study, the different expression
of RPS5 and OAZ1 genes in hyper-osmotic and hypo-
osmotic stimuli samples suggested different response
functions to osmotic conditions in IVD cells.
The SLC25A3 gene encodes a phosphate carrier protein
(also named phosphate transport protein, PTP) which
is a member of the solute carrier (SLC) family and is
located in mitochondria [29]. PTP catalyzes the transport
of phosphate groups from the cytosol to the mitochondrial
matrix, either by proton co-transport or in exchange for
hydroxyl ions [30]. To date, there is no direct evidence
of SLC25A3 ever regulating osmotic pressure, however,
it has been reported that the expressions of SLC21A12,
SLC5A3, and SLC16A6 are regulated by osmotic conditions
in IVD cells, which is consistent with our results [31].
Meanwhile, nucleophosmin (NPM) (also known as nucle-
olar phosphoprotein B23 or numatrin) is encoded by the
NPM1 gene in humans [32,33]. To date, there is no report
revealing the contribution of NPM to IVD. NPM may be
involved in diverse biological functions, such as ribosome
biogenesis and transport, genomic stability and DNA
repair, endoribonuclease activity, and centrosome duplica-
tion during the cell cycle [34-37]. As a result, we inferred
that the changes of expression level of NPM may be
used to explain the changes of IVD cells in sensitivity to os-
motic pressure and the phenomenon of disc degeneration
in old age [38,39]. In our study, we found the expression
level of the SLC25A3 gene to be less than the NPM1 gene
only in iso-stimuli conditions in old age. Therefore, we
inferred that iso-stimuli conditions might be an adverse
factor for IVD cells.
Chromobox protein homolog 3 (HP1 gamma) is encoded
by the CBX3 gene and is involved in chromatin remodeling,
DNA-dependent transcription, and negative regulation of
transcription [40,41]. Furthermore, it has been reported
that HP1 plays an important role in cell survival, by
supporting cell proliferation [33]. Meanwhile, serine/ar-
ginine rich splicing factor 9 (SRSF9), a member of the
serine/arginine-rich protein family, is involved in alter-
native pre-mRNA splicing and plays a critical role in
the regulation of apoptosis by splicing apoptosis-related
genes [42,43]. Therefore, these studies may explain the
lower expression level of the CBX3 gene compared to
that of the SRSF9 gene in our study.
To summarize, we inferred that hyper-osmotic and iso-
osmotic conditions were adverse environmental factors
for IVD cells, which was consistent with a previous study
showing that IVD tissues have a higher extracellular
osmolality than most other tissues [6,7]. However, it
should be pointed out that several limitations were
present in our study. The human IVD tissue samples
were collected from patients aged 63, 62, 50, and 29
years old. The number of gene expression profiles was
limited. Additionally, samples with a wider age range
are needed to further analyze and confirm our inferences.
Further, no computational procedure is perfect; as a result,
potential candidates might be missed. In our study, only
five pairs were identified; however, other important gene
pairs might also be elucidated through other analysis
methods and different samples.
Conclusions
In conclusion, we explored the molecular mechanism of
the different responses of IVD cells in hyper-osmotic,
iso-osmotic, and hypo-osmotic conditions. Finally, five gene
pairs ((CYP2A6, FNTB), (PRPF8, TARDBP), (RPS5, OAZ1),
(SLC25A3, NPM1) and (CBX3, SRSF9)) were selected
based on the TSP method. Our results indicated that the
expression level of these genes was reversed in old age in
different osmotic stimuli conditions, but the expression
level of these genes was not affected at an early age. We
believe our results may provide new information on the
molecular mechanisms of IVD disease.
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